If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
1st Feb 20234:33 pmRNSNet Asset Value(s)
1st Feb 202311:00 amRNSTotal Voting Rights
27th Jan 20233:16 pmRNSNet Asset Value(s)
20th Jan 20234:54 pmRNSTransaction in Own Shares
20th Jan 20233:03 pmRNSNet Asset Value(s)
20th Jan 202310:54 amRNSDirector/PDMR Shareholding
13th Jan 20233:27 pmRNSNet Asset Value(s)
6th Jan 20233:53 pmRNSNet Asset Value(s)
6th Jan 202311:42 amRNSTransaction in Own Shares
3rd Jan 20234:49 pmRNSNet Asset Value(s)
3rd Jan 20239:33 amRNSTotal Voting Rights
23rd Dec 202210:53 amRNSNet Asset Value(s)
22nd Dec 20224:15 pmRNSTransaction in Own Shares
16th Dec 20222:27 pmRNSNet Asset Value(s)
9th Dec 20224:52 pmRNSNet Asset Value(s)
6th Dec 20224:44 pmRNSTransaction in Own Shares
1st Dec 20224:52 pmRNSNet Asset Value(s)
1st Dec 20224:39 pmRNSBoard Committee Change
1st Dec 20224:19 pmRNSTotal Voting Rights
28th Nov 202210:35 amRNSDirector/PDMR Shareholding
25th Nov 20224:56 pmRNSIssue of Equity - DRIS
25th Nov 20223:29 pmRNSNet Asset Value(s)
21st Nov 20222:52 pmRNSTransaction in Own Shares
18th Nov 20224:15 pmRNSNet Asset Value(s)
11th Nov 20223:42 pmRNSNet Asset Value(s)
4th Nov 20222:40 pmRNSNet Asset Value(s)
1st Nov 20225:32 pmRNSNet Asset Value(s)
1st Nov 202210:06 amRNSTotal Voting Rights
24th Oct 202210:45 amRNSNet Asset Value(s)
21st Oct 20223:09 pmRNSTransaction in Own Shares
17th Oct 202212:04 pmRNSNet Asset Value(s)
12th Oct 20225:19 pmRNSTransaction in Own Shares
10th Oct 20222:40 pmRNSNet Asset Value(s)
4th Oct 20221:50 pmRNSNet Asset Value(s)
3rd Oct 20229:16 amRNSTotal Voting Rights
30th Sep 20227:01 amRNSDividend Declaration
30th Sep 20227:00 amRNSHalf-year Report
28th Sep 20223:02 pmRNSTransaction in Own Shares
23rd Sep 20224:09 pmRNSNet Asset Value(s)
23rd Sep 20223:56 pmRNSTransaction in Own Shares
22nd Sep 202210:53 amRNSTransaction in Own Shares
16th Sep 20225:19 pmRNSNet Asset Value(s)
13th Sep 20223:10 pmRNSCancellation of Share Premium Account
9th Sep 20223:02 pmRNSNet Asset Value(s)
7th Sep 20221:56 pmRNSTransaction in Own Shares
2nd Sep 202210:40 amRNSReplacement Total Voting Rights
1st Sep 20225:08 pmRNSTotal Voting Rights
1st Sep 20224:26 pmRNSTransaction in Own Shares
1st Sep 20223:48 pmRNSNet Asset Value(s)
30th Aug 20224:14 pmRNSCompliance with Market Abuse Regulation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.